Update
$Tempest Therapeutics(TPST.US$ Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications 2 MINUTES AGO, 8:00 AM EDT VIA GLOBENEWSWIRE TPST TPST-1120, a first-in-class, oral, selective PPAR⍺ antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised cancers Based on subsequent positive randomized data, Company preparing to move TPST-1120 into pivotal Phase 3 trial in HCC
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Chasing_Freedom : so why is it dropping
adamwky83 : Coz they are flushing out weak hands
Chasing_Freedom adamwky83: I hope I need this to booommmm fr
Chasing_Freedom : 4 6 still strong
TrytosaveabitOP Chasing_Freedom: Seems to be holding! But if it breaks below? Im afraid next S is 4.35. But that seems to be MS! GL